ESR1 and neoplasm: Interestingly, although ER expression was observed in 50 of the 121 (41.3%) patients with CD44/CD24 data, the presence of CD44+/CD24- tumor cells was not significantly correlated with positive ER expression in all patients and in patients with recurrence or metastasis.